
Vir Biotechnology VIR
€ 11.73
-4.63%
Vir Biotechnology ROCE | VIR
ROCE Jährlich Vir Biotechnology
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -52.67 | -45.9 | -39.25 | 36.36 | 26.08 | -36.23 | -39.3 | - | - | - | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 36.36 | -52.67 | -21.56 |
ROCE Vierteljährlich Vir Biotechnology
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -22.75 | -30.97 | -48.42 | -46.45 | -50.34 | -48.72 | -47.91 | -40.7 | -39.51 | -32.7 | -33.28 | -35.14 | -33.74 | -15.64 | -15.5 | 37.48 | 79.5 | 65.86 | 83.08 | 16.19 | -32.48 | -37.13 | -48.53 | -45.14 | -45.99 | -17.42 | -21.15 | -11.31 | 21.93 | -8.44 | -7.26 | - | 19.17 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 83.08 | -50.34 | -15.42 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
PainReform Ltd.
PRFX
|
-58.14 | $ 0.78 | -4.24 % | $ 505 K | ||
|
Prothena Corporation plc
PRTA
|
-75.06 | $ 8.56 | -2.51 % | $ 461 M | ||
|
Arcus Biosciences
RCUS
|
-61.17 | $ 18.66 | -1.56 % | $ 2 B | ||
|
Orgenesis
ORGS
|
155.73 | - | -33.86 % | $ 61.2 M | ||
|
Dr. Reddy's Laboratories Limited
RDY
|
19.81 | $ 14.9 | -1.03 % | $ 12.4 B | ||
|
Regeneron Pharmaceuticals
REGN
|
11.45 | $ 916.16 | -0.41 % | $ 95.8 B | ||
|
Replimune Group
REPL
|
-116.69 | $ 23.3 | 4.67 % | $ 2.16 B | ||
|
Фармсинтез
LIFE
|
-4.03 | - | - | - | ||
|
Royalty Pharma plc
RPRX
|
8.21 | $ 69.47 | 1.02 % | $ 29.9 B | ||
|
Revolution Medicines
RVMD
|
-57.28 | $ 193.0 | -3.57 % | $ 36.7 B | ||
|
Rhythm Pharmaceuticals
RYTM
|
-78.92 | $ 113.99 | 0.04 % | $ 7.41 B | ||
|
Codiak BioSciences
CDAK
|
-129.99 | - | -55.98 % | $ 2.15 M | ||
|
Sana Biotechnology
SANA
|
-74.02 | $ 2.43 | -1.42 % | $ 615 M | ||
|
Sol-Gel Technologies Ltd.
SLGL
|
-31.74 | $ 61.81 | 0.11 % | $ 172 M | ||
|
Summit Therapeutics
SMMT
|
-57.38 | $ 17.78 | -0.34 % | $ 13.3 B | ||
|
Checkpoint Therapeutics
CKPT
|
444.94 | - | - | $ 169 M | ||
|
Syndax Pharmaceuticals
SNDX
|
-66.67 | $ 9.43 | -0.89 % | $ 817 M | ||
|
Spero Therapeutics
SPRO
|
10.7 | $ 1.01 | -5.61 % | $ 56.6 M | ||
|
Sarepta Therapeutics
SRPT
|
-31.04 | $ 16.4 | -5.54 % | $ 1.64 B | ||
|
Tarsus Pharmaceuticals
TARS
|
-16.64 | $ 73.9 | 4.32 % | $ 3.09 B | ||
|
Bio-Techne Corporation
TECH
|
11.95 | $ 72.83 | -0.01 % | $ 11.4 B | ||
|
Sage Therapeutics
SAGE
|
-92.97 | - | - | $ 527 M | ||
|
Taro Pharmaceutical Industries Ltd.
TARO
|
1.01 | - | - | $ 1.62 B | ||
|
Cabaletta Bio
CABA
|
-149.87 | $ 1.43 | -5.0 % | $ 144 M | ||
|
Forma Therapeutics Holdings
FMTX
|
-34.91 | - | - | $ 958 M | ||
|
Blueprint Medicines Corporation
BPMC
|
-60.1 | - | - | $ 8.14 B | ||
|
Horizon Therapeutics Public Limited Company
HZNP
|
7.56 | - | - | $ 26.6 B | ||
|
Tonix Pharmaceuticals Holding Corp.
TNXP
|
-51.03 | $ 4.12 | -8.35 % | $ 35.1 M | ||
|
Paratek Pharmaceuticals
PRTK
|
27.02 | - | - | $ 121 M | ||
|
DBV Technologies S.A.
DBVT
|
-83.7 | $ 11.55 | 4.52 % | $ 1.61 B | ||
|
Gilead Sciences
GILD
|
44.14 | $ 170.68 | 0.8 % | $ 212 B | ||
|
Taysha Gene Therapies
TSHA
|
-44.75 | $ 4.28 | -2.06 % | $ 1.37 B | ||
|
ASLAN Pharmaceuticals Limited
ASLN
|
-379.93 | - | -14.27 % | $ 1.7 M | ||
|
Adverum Biotechnologies
ADVM
|
-196.79 | - | - | $ 86.2 M | ||
|
Unity Biotechnology
UBX
|
-480.0 | - | -33.41 % | $ 3.37 M | ||
|
iTeos Therapeutics
ITOS
|
-27.03 | - | - | $ 411 M | ||
|
Gossamer Bio
GOSS
|
-156.9 | $ 11.2 | 5.21 % | $ 2.56 B | ||
|
GeoVax Labs
GOVX
|
-565.71 | $ 0.11 | -22.17 % | $ 105 K | ||
|
United Therapeutics Corporation
UTHR
|
20.39 | $ 588.33 | 1.01 % | $ 26.1 B | ||
|
Seelos Therapeutics
SEEL
|
120.86 | - | -47.76 % | $ 6.27 M | ||
|
Vericel Corporation
VCEL
|
2.52 | $ 59.02 | 1.08 % | $ 2.97 B | ||
|
Veracyte
VCYT
|
4.29 | $ 24.05 | -7.21 % | $ 1.89 B | ||
|
Advaxis
ADXS
|
429.74 | - | -9.65 % | $ 45.9 M | ||
|
GlaxoSmithKline plc
GSK
|
19.97 | $ 51.25 | -0.56 % | $ 208 B | ||
|
Viking Therapeutics
VKTX
|
-61.55 | $ 28.67 | -1.1 % | $ 3.23 B | ||
|
Vanda Pharmaceuticals
VNDA
|
-43.97 | $ 4.07 | -0.49 % | $ 240 M | ||
|
Verrica Pharmaceuticals
VRCA
|
-49.25 | $ 3.55 | -1.11 % | $ 37.8 M | ||
|
Vertex Pharmaceuticals Incorporated
VRTX
|
19.16 | $ 547.74 | -0.57 % | $ 140 B | ||
|
Kiromic BioPharma
KRBP
|
188.88 | - | 6.61 % | $ 3.08 M |